| # | Drug | Count |
|---|---|---|
| 0 | TREPROSTINIL | 13 |
| 1 | HUMAN IMMUNOGLOBULIN G | 12 |
| 2 | DUPILUMAB | 10 |
| 3 | 0XYGEN | 7 |
| 4 | ALBUTEROL SULFATE | 7 |
| 5 | OXYGEN | 7 |
| 6 | TADALAFIL | 7 |
| 7 | ADALIMUMAB | 6 |
| 8 | EVOLOCUMAB | 6 |
| 9 | SODIUM CHLORIDE | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | LENACAPAVIR SODIUM | 2 | 0.0040 |
| 1 | BRIMONIDINE TARTRATE AND TIMOLOL MALEATE | 1 | 0.0025 |
| 2 | DICLOFENAC SODIUM/MISOPROSTOL | 1 | 0.0023 |
| 3 | SORBITOL | 1 | 0.0017 |
| 4 | APOMORPHINE HYDROCHLORIDE | 2 | 0.0012 |
| 5 | KETAMINE HYDROCHLORIDE | 3 | 0.0006 |
| 6 | HUMAN IMMUNOGLOBULIN G | 12 | 0.0006 |
| 7 | SOTATERCEPT-CSRK | 3 | 0.0005 |
| 8 | FLUDROCORTISONE ACETATE | 1 | 0.0004 |
| 9 | OPICAPONE | 1 | 0.0004 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Antihypoglycemic Agent [EPC] | 1 | 0.0002 |
| 1 | PCSK9 Inhibitor [EPC] | 5 | 0.0002 |
| 2 | Tissue-nonspecific Alkaline Phosphatase [EPC] | 1 | 0.0001 |
| 3 | Prostacycline Vasodilator [EPC] | 13 | 0.0001 |
| 4 | Prostacyclin Receptor Agonist [EPC] | 2 | 0.0001 |
| 5 | Hydrolytic Lysosomal Glycosaminoglycan-specific Enzyme [EPC] | 1 | 0.0001 |
| 6 | Stimulant Laxative [EPC] | 1 | 0.0001 |
| 7 | Leukotriene Receptor Antagonist [EPC] | 2 | 0.0001 |
| 8 | Phosphodiesterase 5 Inhibitor [EPC] | 9 | 0.0001 |
| 9 | Interleukin-31 Receptor alpha Antagonist [EPC] | 1 | 0.0001 |